Galena Biopharma (GALE) Reports Q3 Loss of $0.02/Share
Tweet
Share
E-mail
Get Alerts GALE Hot Sheet
Join SI Premium – FREE
Galena Biopharma (NASDAQ: GALE) reported Q3 EPS of ($0.02), versus ($0.04) reported last year.
For earnings history and earnings-related data on Galena Biopharma (GALE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JPMorgan Upgrades Aviva Plc (AV/:LN) (AIVAF) to Overweight
- Acrivon Therapeutics, Inc. (ACRV) Tops Q2 EPS by 21c
- Pan American Silver (PAAS) Misses Q2 EPS by 19c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
